Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors ; volume:22 ; number:1 ; day:2 ; month:2 ; year:2023 ; pages:1-14 ; date:12.2023
Cardiovascular diabetology ; 22, Heft 1 (2.2.2023), 1-14, 12.2023
- Urheber
-
Scisciola, Lucia
Taktaz, Fatemeh
Fontanella, Rosaria Anna
Pesapane, Ada
Surina
Cataldo, Vittoria
Ghosh, Puja
Franzese, Martina
Puocci, Armando
Paolisso, Pasquale
Rafaniello, Concetta
Marfella, Raffaele
Rizzo, Maria Rosaria
Barbato, Emanuele
Vanderheyden, Marc
Barbieri, Michelangela
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-023-01754-2
- URN
-
urn:nbn:de:101:1-2023040721045977636657
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Scisciola, Lucia
- Taktaz, Fatemeh
- Fontanella, Rosaria Anna
- Pesapane, Ada
- Surina
- Cataldo, Vittoria
- Ghosh, Puja
- Franzese, Martina
- Puocci, Armando
- Paolisso, Pasquale
- Rafaniello, Concetta
- Marfella, Raffaele
- Rizzo, Maria Rosaria
- Barbato, Emanuele
- Vanderheyden, Marc
- Barbieri, Michelangela
- SpringerLink (Online service)
Ähnliche Objekte (12)
SGLT2 and cancer
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells
Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation
Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter
SGLT2-Hemmer : Geringere Mortalität und Nierenschutz
Direct cardiac effects of SGLT2 inhibitors
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
SGLT2 and cancer
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells
Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation
Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter
SGLT2-Hemmer : Geringere Mortalität und Nierenschutz
Direct cardiac effects of SGLT2 inhibitors
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
SGLT2 and cancer
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells
Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation
Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter
SGLT2-Hemmer : Geringere Mortalität und Nierenschutz
Direct cardiac effects of SGLT2 inhibitors
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus